Genetic sequencing uncovers previously unknown viruses in vulnerable sea turtles

A large-scale virome study has identified 19 viruses in sea turtles from the Atlantic and Pacific coasts of the United States, including seven viruses not previously described in any species. The work provides a new baseline for disease surveillance in threatened and endangered sea turtle populations, where viral infections remain poorly characterised.

Researchers at the University of Georgia College of Veterinary Medicine analysed faecal samples collected from rehabilitated and free-ranging sea turtles through a network of marine wildlife specialists. Using genetic sequencing, they identified a much broader viral diversity than had previously been recognised in these animals.

Seven completely new viruses

The study detected 19 viruses in total, including seven novel viruses. One of them appears to belong to a previously unrecognised viral family. Some of the viruses were genetically related to pathogens already known from aquatic invertebrates and fish, suggesting that the sea turtle virome may include viruses associated with both the turtles themselves and their marine environment.

The researchers emphasise that detection alone does not mean that these viruses cause disease. Many may be harmless components of the normal viral community.

The importance of the work lies in establishing a reference catalogue. If an unexplained disease or mortality event occurs in the future, investigators will be able to compare newly detected viruses with those already known to circulate in apparently healthy or clinically stable turtles.

A major gap in sea turtle disease surveillance

Until now, fewer than a dozen viruses had been clearly associated with disease in sea turtles. Research and conservation programmes have consequently focused much more heavily on well-recognised threats such as pollution, fisheries bycatch, poaching, habitat loss and coastal development.

Yet infectious diseases could become particularly important in populations already under pressure. Five of the world’s seven sea turtle species are threatened or endangered, meaning that even relatively localised disease outbreaks could have conservation consequences.

An author had previously helped identify a virus strongly associated with fatal neurological disease in aquatic turtles. That finding prompted the broader question of what other, still-undescribed viruses might be circulating in chelonians.

From “unknown unknowns” to surveillance targets

The study illustrates the value of metagenomic sequencing in wildlife health. Rather than testing only for pathogens already suspected, sequencing can reveal viral material without requiring a predefined target. That makes it particularly useful in species where the infectious-disease landscape is poorly known.

Cataloguing viral diversity converts completely unknown agents into organisms that can subsequently be monitored and investigated. Most may never prove pathogenic, but the few that are associated with disease can then be recognised far more quickly. For vulnerable sea turtle populations, that baseline could be critical. Disease investigations during an outbreak would no longer need to begin from zero.

A new tool for marine wildlife conservation

The study also highlights the growing overlap between wildlife conservation, veterinary pathology and genomic surveillance. Sea turtles are exposed to rapidly changing marine environments, pollution, climate-related ecological shifts and interactions with numerous other aquatic species. Understanding their viral communities adds another layer to assessing population health.

The researchers worked with the Georgia Sea Turtle Center, NOAA-associated specialists, The Turtle Hospital in Florida, Mystic Aquarium, New England Aquarium and Upwell in California, allowing sampling across both the Atlantic and Pacific coasts.

The findings do not indicate an immediate new viral epidemic in sea turtles. Instead, they provide something that has largely been missing: a baseline map of viral diversity against which future disease events can be compared.